000 01504 a2200409 4500
005 20250515024617.0
264 0 _c20060615
008 200606s 0 0 eng d
022 _a1050-7256
024 7 _a10.1089/thy.2006.16.177
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTaïeb, D
245 0 0 _aEarly sequential changes in serum thyroglobulin after radioiodine ablation for thyroid cancer: possible clinical implications for recombinant human thyrotropin-aided therapy.
_h[electronic resource]
260 _bThyroid : official journal of the American Thyroid Association
_cFeb 2006
300 _a177-9 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aCell Differentiation
650 0 4 _aHumans
650 0 4 _aHypothyroidism
650 0 4 _aIodine Radioisotopes
_xtherapeutic use
650 0 4 _aModels, Statistical
650 0 4 _aPredictive Value of Tests
650 0 4 _aRecombinant Proteins
_xchemistry
650 0 4 _aSoftware
650 0 4 _aThyroglobulin
_xblood
650 0 4 _aThyroid Neoplasms
_xdiagnosis
650 0 4 _aThyrotropin
_xblood
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aLussato, D
700 1 _aGuedj, E
700 1 _aRoux, F
700 1 _aMundler, O
773 0 _tThyroid : official journal of the American Thyroid Association
_gvol. 16
_gno. 2
_gp. 177-9
856 4 0 _uhttps://doi.org/10.1089/thy.2006.16.177
_zAvailable from publisher's website
999 _c16277589
_d16277589